Taishan Medical Forum |JIANPAI Technology Shares Three-in-One “Smart” Granulation Machine Leading the Upgrade of Granulation Technology

The 4th Taishan Pharmaceutical Forum grandly opened in Jinan on November 10th. The forum, themed “Whole Industry, Large Platform, Deep Integration, and Common Development,” brought together over 500 pharmaceutical industry leaders, experts, scholars, and enterprise representatives from across the country to discuss new paths for high-quality development of the pharmaceutical industry. The forum was jointly organized by the Taishan Pharmaceutical Forum Organizing Committee and 13 leading companies in the industry: Yangtze River Pharmaceutical Group, Xiuzheng Pharmaceutical Group, Jinmu Group, Natong Medical Technology Group, Haobang Pharmaceutical Group, Kuihua Pharmaceutical Group, Jingzhu Tibetan Medicine Group, Jinan South Suburb Hospital, Langou Pharmaceutical Group, China Stem Cell Group, Shuyu Pingmin Pharmacy, Shandong Ronghetang Pharmaceutical Group, and Hankang Pharmaceutical. Covering the entire pharmaceutical industry chain, including R&D, production, distribution, and end-users, the forum established a high-level, multi-dimensional platform for exchange and cooperation.

At the “Innovation-Driven, Intelligent Future” seminar on high-quality development of pharmaceutical equipment, the first event was an awarding ceremony for experts in the pharmaceutical equipment field from the Expert Committee of the All-China Federation of Industry and Commerce Pharmaceutical Industry Chamber of Commerce. Wang Juechong, Chairman and Chief Engineer of Zhejiang JIANPAI Machinery Technology Co., Ltd., was awarded an expert appointment certificate. This honor recognizes his more than 30 years of dedication to the industry and demonstrates JIANPAI Technology’s professional influence in the pharmaceutical equipment field.

Subsequently, Wang Juechong was invited to deliver a keynote speech entitled “Integration, Intelligence, and Efficiency: The Three-in-One Smart Granulator Leads a New Revolution in Granulation Technology,” sharing the company’s latest achievements in solid dosage form technology and equipment innovation.

In his speech, Wang Juechong pointed out that JIANPAI Technology’s independently developed high-efficiency three-in-one granulator integrates wet granulation, fluidized bed drying, and dry granulation into a single platform through an integrated design. This achieves a closed-loop production process from material feeding to granulation, eliminating pollution and loss caused by material turnover and significantly improving production efficiency and product quality. The equipment boasts core features such as three process functions, three independent operating modes, coverage of three process areas, and applications in three industries. It not only achieves a synergistic effect of 1+1+1>3 in technology but also reaches industry-leading levels in particle uniformity, density control, and process stability, making it particularly suitable for fields with stringent process requirements, such as traditional Chinese medicine, chemical drugs, and health products. Wang Juechong stated, “Over thirty years of experience in the industry has convinced me that technological innovation as the engine and customer needs as the guide are the eternal missions of pharmaceutical equipment companies. JIANPAI is willing to join hands with industry colleagues to contribute to China’s pharmaceutical industry with more intelligent, efficient, and reliable equipment.”

Following the seminar, the second Director’s Office Meeting of the Pharmaceutical Equipment Committee in 2025 was held concurrently. The meeting focused on “Building a New Ecosystem for the Pharmaceutical Industry,” proposing further integration of upstream and downstream enterprise resources, breaking down industry barriers, and constructing a collaborative and efficient industrial cooperation network, striving to provide multi-level, multi-functional, and comprehensive public innovation services for the entire pharmaceutical industry chain. Chairman Wang Juechong, as the Executive Director of the Pharmaceutical Equipment Committee of the All-China Federation of Pharmaceutical Chambers of Commerce, was invited to attend the meeting.

This Taishan Pharmaceutical Forum not only provided a platform for in-depth exchanges among all parties in the pharmaceutical industry chain, but also offered a stage for technology-driven companies like JIANPAI Technology to showcase their innovative strengths and drive industry progress. In the future, JIANPAI will continue to focus on the pharmaceutical equipment field, using its intelligent, integrated, and green product philosophy to help China’s pharmaceutical industry move towards a higher quality development path.

News Source: Taishan Medical Forum Official WeChat Account

Company Profile

Zhejiang JIANPAI Machinery Technology Co., Ltd. was founded in 1997 and is a well-known domestic supplier of pharmaceutical solid dosage equipment. It is a national high-tech enterprise, a project undertaker of the National Torch Program, and a Zhejiang Province Specialized and New Enterprise.
JIANPAI Technology’s main product series include: mixing equipment, high-efficiency sugar coating and film coating equipment, crushing equipment, granulating equipment, drying equipment, lifting and transferring equipment, cleaning equipment, and fully enclosed solid dosage linkage lines.